Key result
Precision medicine for antithrombotic therapy after percutaneous coronary interventions requires individualized strategies based on clinical, procedural, and genetic factors to balance ischemic and bleeding risks.
No takes yet. Share an insight, caveat, or question.
Galli et al. (2023) conducted an editorial in Percutaneous coronary interventions. Precision medicine for antithrombotic therapy was evaluated. Precision medicine for antithrombotic therapy after percutaneous coronary interventions requires individualized strategies based on clinical, procedural, and genetic factors to balance ischemic and bleeding risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: